Related references
Note: Only part of the references are listed.Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Cross-regulation between type I and type IINKT cells in regulating tumor immunity: A new immunoregulatory axis
Elena Ambrosino et al.
JOURNAL OF IMMUNOLOGY (2007)
Arginine metabolism in tumor-associated macrophages in cutaneous malignant melanoma: evidence from human and experimental tumors
Danieta Massi et al.
HUMAN PATHOLOGY (2007)
Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses
Timothy L. Denning et al.
NATURE IMMUNOLOGY (2007)
Nitric oxide induces CD4+CD25+ Foxp3- regulatory T cells from CD4+CD25- T cells via p53, IL-2, and OX40
Wanda Niedbala et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses
Ingo Fricke et al.
CLINICAL CANCER RESEARCH (2007)
Metabolic mechanisms of cancer-induced inhibition of immune responses
Antonella Viola et al.
SEMINARS IN CANCER BIOLOGY (2007)
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Csaba Szabo et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei et al.
NATURE BIOTECHNOLOGY (2007)
A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
Hyun-Jeong Ko et al.
CANCER RESEARCH (2007)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Human IL4I1 is a secreted L-phenylalanine oxidase expressed by mature dendritic cells that inhibits T-lymphocyte proliferation
Marie-Laure Boulland et al.
BLOOD (2007)
Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1
R. Tedjo Sasmono et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Cunren Liu et al.
BLOOD (2007)
Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
Caroline Aspord et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Altered macrophage differentiation and immune dysfunction in tumor development
Antonio Sica et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Indoleamine 2,3-dioxygenase and tumor-induced tolerance
David H. Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Swords into plowshares: IL-23 repurposes tumor immune surveillance
John L. Langowski et al.
TRENDS IN IMMUNOLOGY (2007)
L-arginine availability regulates T-lymphocyte cell-cycle progression
Paulo C. Rodriguez et al.
BLOOD (2007)
Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressor cell expansion
James E. Talmadge et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
Tumor signaling to the bone marrow changes the phenotype of monocytes and pulmonary macrophages during urethane-induced primary lung tumorigenesis in A/J mice
Elizabeth F. Redente et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients
G. Parmiani et al.
ANNALS OF ONCOLOGY (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Myeloid suppressor cell-associated immune dysfunction in CSA1M fibrosarcoma tumor-bearing mice
Ru Zhou et al.
CANCER SCIENCE (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al.
CANCER RESEARCH (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Giovanna Gallina et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
TCR ζ down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs
Analia V. Ezernitchi et al.
JOURNAL OF IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes
Roberta Valenti et al.
CANCER RESEARCH (2006)
Leukocyte infiltration in cancer creates an unfavorable environment for antitumor immune responses: A novel target for therapeutic intervention
Vincenzo Bronte et al.
IMMUNOLOGICAL INVESTIGATIONS (2006)
Suppression of antitumor immunity by IL-10 and TGF-β-producing T cells infiltrating the growing tumor:: Influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells
Andrew G. Jarnicki et al.
JOURNAL OF IMMUNOLOGY (2006)
CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells
Rongcun Yang et al.
CANCER RESEARCH (2006)
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells
Francesca Fallarino et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation
DH Munn
CURRENT OPINION IN IMMUNOLOGY (2006)
Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression
P Serafini et al.
SEMINARS IN CANCER BIOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression
SK Bunt et al.
JOURNAL OF IMMUNOLOGY (2006)
Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis
P Sinha et al.
CANCER RESEARCH (2005)
Granulocyte colony-stimulating factor: A novel mediator of T cell tolerance
S Rutella et al.
JOURNAL OF IMMUNOLOGY (2005)
Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro
S Rössner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
P Sinha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity
E Suzuki et al.
CLINICAL CANCER RESEARCH (2005)
Heparin-binding sites in granulocyte-macrophage colony-stimulating factor - Localization and regulation by histidine ionization
A Sebollela et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Regulation of immune responses by L- arginine metabolism
V Bronte et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Drug Insight:: oral phosphodiesterase type 5 inhibitors for erectile dysfunction
A Briganti et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
V Bronte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
L-Arginine regulates neuronal nitric oxide synthase production of superoxide and hydrogen peroxide
P Tsai et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen
CG Drake et al.
CANCER CELL (2005)
Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease
P Sinha et al.
JOURNAL OF IMMUNOLOGY (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Role of IL-13 in regulation of anti-tumor immunity and tumor growth
M Terabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Derangement of immune responses by myeloid suppressor cells
P Serafini et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Human T regulatory cells can use the perforin pathway to cause autologous target cell death
WJ Grossman et al.
IMMUNITY (2004)
IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation
SJ Park et al.
JOURNAL OF IMMUNOLOGY (2004)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses
PC Rodriguez et al.
CANCER RESEARCH (2004)
Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus
Y Tsuda et al.
IMMUNITY (2004)
Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors
CS Hsieh et al.
IMMUNITY (2004)
Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes
DH Munn et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Inhibition of experimental asthma by indoleamine 2,3-dioxygenase
T Hayashi et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells
E Obermueller et al.
CANCER RESEARCH (2004)
Role of infiltrated leucocytes in tumour growth and spread
EY Lin et al.
BRITISH JOURNAL OF CANCER (2004)
Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang et al.
CANCER CELL (2004)
IDO expression by dendritic cells: Tolerance and tryptophan catabolism
AL Mellor et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy
HY Wang et al.
IMMUNITY (2004)
Modulation of tryptophan catabolism by regulatory T cells
F Fallarino et al.
NATURE IMMUNOLOGY (2003)
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
G Gasparini et al.
LANCET ONCOLOGY (2003)
Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity
C Melani et al.
BLOOD (2003)
L-arginine consumption by macrophages modulates the expression of CD3ξ chain in T lymphocytes
PC Rodriguez et al.
JOURNAL OF IMMUNOLOGY (2003)
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
S Kusmartsev et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
GM-CSF-secreting melanoma vaccines
G Dranoff
ONCOGENE (2003)
Tolerance, DCs and tryptophan: much ado about IDO
U Grohmann et al.
TRENDS IN IMMUNOLOGY (2003)
Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic study
S Fiorucci et al.
GASTROENTEROLOGY (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing mice
V Bronte et al.
JOURNAL OF IMMUNOLOGY (2003)
CTLA-4-Ig regulates tryptophan catabolism in vivo
U Grohmann et al.
NATURE IMMUNOLOGY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells
T Natori et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Plasminogen- and colony-stimulating factor-1-associated markers in bladder carcinoma: diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis
P Champelovier et al.
UROLOGICAL RESEARCH (2002)
CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis
A Mencacci et al.
JOURNAL OF IMMUNOLOGY (2002)
Immature myeloid cells and cancer-associated immune suppression
S Kusmartsev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1)
SS Chavan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION (2002)
The macrophage growth factor CSF-1 in mammary gland development and tumor progression
EY Lin et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2002)
Effects of arginase isoforms on NO production by nNOS
LG Que et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2002)
Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase by macrophage-stimulating protein results in the induction of arginase activity in murine peritoneal macrophages
AC Morrison et al.
JOURNAL OF IMMUNOLOGY (2002)
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2002)
Tumor-induced immune dysfunctions caused by myeloid suppressor cells
V Bronte et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Secretion of GM-CSF and M-CSF by human renal cell carcinomas of different histologic
CD Gerharz et al.
UROLOGY (2001)
Tumor-derived granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor prolong the survival of neutrophils infiltrating bronchoalveolar subtype pulmonary adenocarcinoma
M Wislez et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor
MM Mueller et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-κB
RW Ganster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Safeguarding patients in clinical trials with high mortality rates
BD Freeman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Activation of cGMP-dependent protein kinase Iβ inhibits interleukin 2 release and proliferation of T cell receptor-stimulated human peripheral T cells
TA Fischer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production
R Rutschman et al.
JOURNAL OF IMMUNOLOGY (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway
M Terabe et al.
NATURE IMMUNOLOGY (2000)
Resection of solid tumors reverses T cell defects and restores protective immunity
S Salvadori et al.
JOURNAL OF IMMUNOLOGY (2000)
TIA-1 positive tumor-infiltrating lymphocytes in nevi and melanomas
S Lyle et al.
MODERN PATHOLOGY (2000)
Possible paracrine growth of adenocarcinoma of the stomach induced by granulocyte colony stimulating factor produced by squamous cell carcinoma of the oesophagus
E Ichiishi et al.
GUT (2000)
Share Paper
